F605 Part 2 reviews CMS expectations for the appropriate use of psychotropic medications, including the requirement that non‑pharmacological interventions be attempted unless clinically contraindicated. This post discusses the regulatory standards for gradual dose reductions (GDRs), including CMS’s expectation that reductions occur in modest increments over adequate periods of time to monitor for symptom recurrence and minimize withdrawal effects. It also highlights the importance of thorough documentation when a GDR is attempted, the prohibition on using medications for staff convenience or discipline, and the resident’s right to informed consent under F552. Survey citation examples illustrate how noncompliance is commonly identified.